Insider Stock Trading History of Mcminn Rachel


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Mcminn Rachel since year 2005. The trader's CIK number is 1606302. At the time of this reporting, Mcminn Rachel is the Chief Strategy Officer of Intercept Pharmaceuticals Inc . (stock ticker symbol ICPT). See this page for all insider trading activities at Intercept Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Mcminn Rachel since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-10-02 ICPT Intercept Pharmaceuticals Inc Sale 283 58.89 16,666
2017-07-31 ICPT Intercept Pharmaceuticals Inc Sale 130 123.12 16,005
2017-07-03 ICPT Intercept Pharmaceuticals Inc Sale 257 121.78 31,297
2017-05-01 ICPT Intercept Pharmaceuticals Inc Sale 114 113.12 12,895
2017-04-03 ICPT Intercept Pharmaceuticals Inc Sale 257 115.00 29,554
2017-01-03 ICPT Intercept Pharmaceuticals Inc Sale 816 103.92 84,797
2016-10-31 ICPT Intercept Pharmaceuticals Inc Sale 129 123.82 15,972
2016-08-01 ICPT Intercept Pharmaceuticals Inc Sale 125 176.56 22,070
2016-07-05 ICPT Intercept Pharmaceuticals Inc Sale 106 145.11 15,381
2016-05-02 ICPT Intercept Pharmaceuticals Inc Sale 130 147.49 19,173
2016-04-04 ICPT Intercept Pharmaceuticals Inc Sale 104 130.76 13,599
2016-02-01 ICPT Intercept Pharmaceuticals Inc Sale 128 103.56 13,255
2016-01-04 ICPT Intercept Pharmaceuticals Inc Sale 469 145.90 68,428
2015-11-02 ICPT Intercept Pharmaceuticals Inc Sale 125 160.24 20,029
2015-07-31 ICPT Intercept Pharmaceuticals Inc Sale 127 262.09 33,285
2015-05-01 ICPT Intercept Pharmaceuticals Inc Sale 503 255.12 128,327

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mcminn Rachel (Chief Strategy Officer of Intercept Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.